| Unique ID issued by UMIN | UMIN000055334 |
|---|---|
| Receipt number | R000063214 |
| Scientific Title | Hypothesis generating study to assess 3-month personal health record (Fitbit) retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement |
| Date of disclosure of the study information | 2024/08/28 |
| Last modified on | 2025/02/04 11:59:18 |
Study to assess 3-month Fitbit retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement
Study to assess 3-month Fitbit retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement
Hypothesis generating study to assess 3-month personal health record (Fitbit) retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement
Hypothesis generating study to assess 3-month personal health record (Fitbit) retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement
| Japan |
severe aortic valve stenosis
| Cardiology | Rehabilitation medicine |
Others
NO
A single-center, single-arm, hypothesis-generating intervention study was designed to determine the primary outcome of 3-month retention of a wristwatch personal health record (PHR) (hereafter referred to as Fitbit) in patients undergoing transcatheter aortic valve implantation (TAVI). A single-center, single-arm, hypothesis-generating intervention study was designed with a primary outcome of retention of wristwatch personal health record (PHR) (henceforth Fitbit) use. Secondary outcomes will be the representative values of heart rate and step rate measured by Fitbit, as well as the 6-minute walk test, which will be evaluated over time. This study focuses on confirming the acceptability of Fitbit in the TAVI patient population for the very elderly and frail.
Efficacy
Exploratory
Not applicable
Percentage of Fitbit wearers who continue to wear the Fitbit at 3 months after TAVI
1) The following items at the beginning of the intervention and 3 months later
6-minute walking distance over time
2) Representative values (mean, median, mode, maximum, and minimum) of number of steps and heart rate measured by Fitbit
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
| Other |
Patients indicated for TAVI will be fitted with a wearable device (Fitbit) at the start of their first post-TAVI exercise rehearsal.
The primary outcome will be the 3-month retention rate of wearing the Fitbit, with Day 0 as the initial rehabilitation period.
The target number of patients is 30.
The number of interventions will be the 6-minute walk test at the beginning of the initial exercise rehearsal and at the end of the 3-month exercise rehearsal.
| 60 | years-old | <= |
| Not applicable |
Male and Female
Patients who meet all of the following criteria are eligible
1) Patients who have undergone TAVI in severe aortic stenosis
2) Patients aged 60 years or older at the time of consent (regardless of gender)
3) Research subjects who have given a full explanation of their participation in this study and have given their free written consent.
4) Patients scheduled for outpatient cardiac rehabilitation
Patients who violate any of the following conditions will not be included in this study
1) Patients who do not have a reliable Internet connection at home, do not have a smartphone, or are otherwise unable to establish a Fitbit use environment.
2) Patients for whom exercise therapy is contraindicated
3) Patients who have difficulty performing the exercise tolerance test due to other diseases or pain
4) Patients who have difficulty operating the Fitbit due to visual or hearing impairment
5) Patients who have experienced hypotension, fatal arrhythmia, or other adverse events during cardiac rehabilitation, exercise stress tests, or exercise therapy.
5) Patients who have experienced hypotension, fatal arrhythmia or other adverse events during cardiac rehabilitation, exercise testing or exercise therapy
6) Patients scheduled to undergo inpatient cardiac rehabilitation for more than 4 weeks
7) Patients who have participated in other clinical trials or clinical studies involving interventions within the past 12 weeks of obtaining consent
8) Patients who the investigator determines to be incapable of correctly understanding the significance of the research and complying with the compliance requirements due to dementia, mental illness, etc.
9) Other patients who are judged by the principal investigator to be inappropriate as research subjects
30
| 1st name | Shigeru |
| Middle name | |
| Last name | Saito |
Shonan Kamakura General Hospital
Cardiac Center
247-8533
1370-1 Okamoto,Kamakura-City
0467-46-1717
transradial@kamakuraheart.org
| 1st name | Futoshi |
| Middle name | |
| Last name | Yamanaka |
Shonan Kamakura General Hospital
Cardiac Center
247-8533
1370-1 Okamoto,Kamakura-City
0467-46-1717
futoshi.yamanaka@gmail.com
Shonan Kamakura General Hospital
None
Other
The Tokushukai Group Ethics Commitee
15F, Tokyo-Do Chiyoda Bldg. 1-3-1 Kudan-Minami, Chiyoda-ku, Tokyo, Japan
0332634801
crb_itoku@shonankamakura.or.jp
NO
| 2024 | Year | 08 | Month | 28 | Day |
Unpublished
Open public recruiting
| 2024 | Year | 08 | Month | 19 | Day |
| 2024 | Year | 08 | Month | 27 | Day |
| 2025 | Year | 02 | Month | 01 | Day |
| 2025 | Year | 09 | Month | 30 | Day |
| 2026 | Year | 01 | Month | 31 | Day |
| 2024 | Year | 08 | Month | 26 | Day |
| 2025 | Year | 02 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063214